| Patient | Ida B. Wells |
|---|---|
| Date of birth | 1957-07-16 |
| Identifiers | MRN HR-ET022-SYN; SSN (made up) 000-22-5903 |
| Document date | 2026-01-20 |
| Author | Emeka Lindqvist-Moore, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New chronic kidney disease, probably G3b A2, of uncertain cause in a 68-year-old Black woman with tiredness, ankle swelling and high blood pressure readings: race-free eGFR 40 by creatinine and 38 with cystatin C, and a urine albumin-to-creatinine ratio of 240 mg/g. Please advise on the cause and further evaluation, APOL1 genetic testing, kidney-protective treatment and its order, the anemia and mineral findings, and how and when to plan for the future. [S]
Urgency: Within two weeks, on the day of her two-week visit, after the repeat urine test and the kidney ultrasound. [S]
Questions for the consultant:
Mrs. Wells, 68, is seen at the request of Dr. Ashworth-Banks for chronic kidney disease found two weeks ago. She has been tired for some months and has had ankle swelling by evening. She took naproxen for knee aching for about a year and stopped it two weeks ago. She has no diabetes, no visible blood in the urine, no foamy urine, no rash, joint swelling or mouth ulcers, and no history of kidney stones or urinary infections. She brought an outside report from two years ago: creatinine 1.05 mg/dL with an eGFR of 64 reported as normal, from an equation with a race coefficient. Her home blood pressure average over seven days is 150/88. She asked detailed questions and wants the evidence behind each recommendation. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee aching (no more than 3,000 mg a day), in place of naproxen | One or two tablets up to three times a day as needed | Oral route | 2026-01-05 | active | S |
| Losartan 50 mg oral tablet, one tablet daily; hold on days of vomiting, diarrhea or not eating | One tablet daily, with sick-day rules | Oral route | 2026-01-20 to 2026-03-03 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-01-20 | active | S |
| Cholecalciferol (vitamin D3) 25 mcg (1,000 units) oral tablet, one tablet daily | One tablet daily | Oral route | 2026-01-20 | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tiredness for some months and ankle swelling by evening, with a raised creatinine (1.42 mg/dL, race-free eGFR 40, confirmed at 38 with cystatin C) and albumin in the urine (240 mg/g) found today; cause and chronicity to be established | resolved | confirmed | R94.4 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks. |
| Elevated blood pressure at intake (164/94 mmHg, average of two readings), without a diagnosis of hypertension; home readings for one week to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
| Hypertension, stage 2, confirmed by home readings (average 150/88 mmHg), with chronic kidney disease | active | confirmed | I12.9 | S — Synthetic modern diagnosis; no blood pressure from her life is recorded. |
| Chronic kidney disease G3b A2 (eGFR 38 by creatinine and cystatin C, urine albumin-to-creatinine ratio 240 and 228 mg/g), present at least two years; small, echogenic kidneys without obstruction; most likely hypertensive kidney disease, with APOL1-associated disease possible; 5-year kidney failure risk about 7% | active | confirmed | N18.32 | S — Synthetic modern diagnosis linked to the kidney disease recorded at her death. |
| Anemia of chronic kidney disease, mild (hemoglobin 11.2 g/dL) with adequate iron stores; a likely part of her tiredness | active | confirmed | D63.1 | S — Synthetic laboratory finding. |
| Vitamin D deficiency (25-hydroxyvitamin D 17 ng/mL) with a mildly raised PTH (84 pg/mL); calcium and phosphate normal | active | confirmed | E55.9 | S — Synthetic laboratory finding, part of the mineral and bone check in kidney disease. |
Vital signs recorded on 2026-01-20; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| Vital signs | Blood pressure 154/90 and pulse 76, measured in clinic today |
| Cardiovascular | Regular rhythm; no rub; trace ankle swelling |
| Skin and joints | No rash; no joint swelling |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-20 | Albumin/Creatinine [Mass Ratio] in Urine | 228 | mg/g | Below 30 mg/g normal (A1); 30 to 300 moderately increased (A2); above 300 severely increased (A3) | High | S |
Data reviewed: Intake results as listed by Dr. Ashworth-Banks. Recalculated earlier value: eGFR 59 by the race-free CKD-EPI 2021 equation (64 by the older race-based equation). Today's results by the older equation would read 44. Urine albumin-to-creatinine ratio 228 mg/g today (240 at intake). Urinalysis: 1+ protein, no blood, no casts; bland sediment. Serum protein electrophoresis: no monoclonal protein; free light chain ratio 1.2, normal for her eGFR. Hepatitis B surface antigen, hepatitis C antibody and HIV negative; hepatitis B surface antibody negative. Kidney ultrasound this morning: right kidney 9.6 cm, left 9.4 cm, both echogenic with thinned cortex, no hydronephrosis, stones or masses. ECG with voltage criteria for left ventricular hypertrophy. Kidney failure risk equation: about 7% at 5 years, 2% at 2 years. [S]